Paratek Pharmaceuticals
Paratek Pharmaceuticals Modernizes Its Digital Presence with a Dynamic, Scalable Umbraco Website
Background
Paratek sought to build a website that would elevate their digital presence, strengthen their credibility, and clearly communicate their mission and value proposition. The site needed to address multiple audiences—investors, potential investors, job seekers, and the medical community—by providing timely, relevant information and a clear answer to the question: “Why should I invest in or work for Paratek?”
One of the key challenges was transitioning from a static site to a dynamic, easy-to-manage content management system (CMS) that would allow non-technical users to make updates quickly and efficiently. Paratek required the ability to continuously publish fresh content as new drugs and research initiatives were introduced, without relying on developers.
Additionally, the site needed to integrate seamlessly with external data sources such as NASDAQ for real-time stock updates, while ensuring content integrity and brand consistency through a controlled publishing workflow.
Solution
Wakefly collaborated closely with Paratek’s marketing and communications teams to design and develop a new website that balanced scientific credibility with modern aesthetics. Guided by Paratek’s brand direction, Wakefly built the new site on the Umbraco CMS, a powerful yet user-friendly platform that provided the flexibility and scalability needed for ongoing growth.
The migration from a static site to Umbraco transformed how Paratek managed its content. Wakefly implemented a custom workflow for content approval and publishing, allowing the Paratek team to maintain editorial oversight while empowering multiple contributors to create and update content. This ensured that new drug information, corporate updates, and investor materials could be published efficiently and accurately.
To meet investor communication needs, Wakefly also integrated NASDAQ stock data directly into the website, providing real-time updates to visitors. The inclusion of Active Directory Single Sign-On (SSO) simplified user access management and improved security, especially for internal stakeholders.
The end result was a dynamic, visually engaging website that not only reflected Paratek’s innovative spirit but also provided the flexibility to evolve alongside the company’s growth.
0%
increase in users
0%
increase in sessions
0%
increase in contact form submissions
Impact
The launch of the new ParatekPharma.com marked a major step forward in Paratek’s digital transformation. The new Umbraco-powered website gave the company complete control over its online content, allowing internal teams to easily manage pages, update investor information, and publish new product details without technical assistance.